ClinicalTrials.gov
ClinicalTrials.gov Menu

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01273142
Recruitment Status : Unknown
Verified December 2010 by Henan Provincial Hospital.
Recruitment status was:  Not yet recruiting
First Posted : January 10, 2011
Last Update Posted : January 10, 2011
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Henan Provincial Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2012
  Estimated Study Completion Date : December 2012